{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:40:08Z","timestamp":1765431608810,"version":"3.46.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-025-10587-y","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:35:14Z","timestamp":1765431314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Victoria and Victor: event-driven lessons for integrating vericiguat into practice and reducing residual risk in HFrEF"],"prefix":"10.1007","volume":"31","author":[{"given":"Kalliopi","family":"Keramida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Musella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Abdelhamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Harrrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Ambrosy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"11","key":"10587_CR1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/ejhf.2720","volume":"24","author":"J Butler","year":"2022","unstructured":"Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA et al (2022) Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum. Eur J Heart Fail 24(11):2029\u201336","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10587_CR2","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1111\/cts.13677","volume":"16","author":"ME Trujillo","year":"2023","unstructured":"Trujillo ME, Ayalasomayajula S, Blaustein RO, Gheyas F (2023) Vericiguat, a novel sGC stimulator: mechanism of action, clinical, and translational science. Clin Transl Sci 16(12):2458\u201366","journal-title":"Clin Transl Sci"},{"issue":"21","key":"10587_CR3","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2015.15734","volume":"314","author":"M Gheorghiade","year":"2015","unstructured":"Gheorghiade M, Greene SJ, Butler J, Filippatos G, Lam CS, Maggioni AP et al (2015) Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial. JAMA 314(21):2251\u201362","journal-title":"JAMA"},{"issue":"15","key":"10587_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","volume":"38","author":"B Pieske","year":"2017","unstructured":"Pieske B, Maggioni AP, Lam CSP, Pieske-Kraigher E, Filippatos G, Butler J et al (2017) Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J 38(15):1119\u201327","journal-title":"Eur Heart J"},{"issue":"15","key":"10587_CR5","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1001\/jama.2020.15922","volume":"324","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O\u2019Connor CM et al (2020) Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial. JAMA 324(15):1512\u20131521","journal-title":"JAMA"},{"issue":"2","key":"10587_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","volume":"6","author":"PW Armstrong","year":"2018","unstructured":"Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA et al (2018) A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator: the VICTORIA trial. JACC Heart Fail 6(2):96\u2013104","journal-title":"JACC Heart Fail"},{"issue":"20","key":"10587_CR7","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382(20):1883\u20131893","journal-title":"N Engl J Med"},{"issue":"2","key":"10587_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ejhf.3501","volume":"27","author":"YNV Reddy","year":"2025","unstructured":"Reddy YNV, Butler J, Anstrom KJ, Blaustein RO, Bonaca MP, Corda S et al (2025) <article-title update=\"added\">Vericiguat global study in participants with chronic heart failure: design of the <scp>VICTOR<\/scp> trial. Eur J Heart Fail 27(2):209\u201318","journal-title":"Eur J Heart Fail"},{"key":"10587_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01665-4","author":"J Butler","year":"2025","unstructured":"Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M et al (2025) Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(25)01665-4","journal-title":"Lancet"},{"key":"10587_CR10","doi-asserted-by":"crossref","unstructured":"Zannad F, Reddy YNV, Barash I, Anstrom KJ, Bonaca MP, Borentain M et al (2025) Effect of vericiguat on worsening heart failure in compensated outpatients with hfref: insights from VICTOR. J Am Coll Cardiol","DOI":"10.1016\/j.jacc.2025.08.051"},{"key":"10587_CR11","unstructured":"Zannad F, O\u2019Connor CM, Butler J, McMullan CJ, Anstrom KJ, Barash I et al (2025) Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. Lancet (London, England)"},{"issue":"18","key":"10587_CR12","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1161\/CIRCULATIONAHA.121.056797","volume":"144","author":"JA Ezekowitz","year":"2021","unstructured":"Ezekowitz JA, Zheng Y, Cohen-Solal A, Melenovsk\u00fd V, Escobedo J, Butler J et al (2021) Hemoglobin and clinical outcomes in the vericiguat global study in patients with heart failure and reduced ejection fraction (VICTORIA). Circulation 144(18):1489\u20131499","journal-title":"Circulation"},{"issue":"13","key":"10587_CR13","doi-asserted-by":"publisher","first-page":"e029071","DOI":"10.1161\/JAHA.122.029071","volume":"12","author":"D D\u2019Amario","year":"2023","unstructured":"D\u2019Amario D, Rodolico D, Delvinioti A, Laborante R, Iacomini C, Masciocchi C et al (2023) Eligibility for the 4 Pharmacological pillars in heart failure with reduced ejection fraction at discharge. J Am Heart Association 12(13):e029071","journal-title":"J Am Heart Association"},{"issue":"2","key":"10587_CR14","doi-asserted-by":"publisher","first-page":"e088998","DOI":"10.1136\/bmjopen-2024-088998","volume":"15","author":"R Laborante","year":"2025","unstructured":"Laborante R, Delvinioti A, Tudor AM, Lenkowicz J, Iacomini C, Iaconelli A et al (2025) Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from generator heart failure datamart. BMJ Open 15(2):e088998","journal-title":"BMJ Open"},{"issue":"8","key":"10587_CR15","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jchf.2024.03.001","volume":"12","author":"SJ Greene","year":"2024","unstructured":"Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW et al (2024) Eligibility and projected benefits of rapid initiation of quadruple therapy for newly diagnosed heart failure. JACC Heart Fail 12(8):1365\u201377","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10587_CR16","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.clinme.2025.100296","volume":"25","author":"S Sze","year":"2025","unstructured":"Sze S, Thaitirarot C, Krishnan S, Chan D, Nicolson W, Squire I et al (2025) Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: A real-world experience. Clin Med 25(2):100296","journal-title":"Clin Med"},{"issue":"6","key":"10587_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ejhf.2149","volume":"23","author":"M Packer","year":"2021","unstructured":"Packer M, McMurray JJV (2021) Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction. Eur J Heart Fail 23(6):882\u2013894","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10587_CR18","doi-asserted-by":"publisher","first-page":"e009337","DOI":"10.1161\/CIRCHEARTFAILURE.121.009337","volume":"15","author":"J Butler","year":"2022","unstructured":"Butler J, Stebbins A, Melenovsk\u00fd V, Sweitzer NK, Cowie MR, Stehlik J et al (2022) Vericiguat and Health-Related quality of life in patients with heart failure with reduced ejection fraction: insights from the VICTORIA trial. Circulation Heart Fail 15(6):e009337","journal-title":"Circulation Heart Fail"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10587-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-025-10587-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-025-10587-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T05:35:15Z","timestamp":1765431315000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-025-10587-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10587"],"URL":"https:\/\/doi.org\/10.1007\/s10741-025-10587-y","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}